Is a prior ischemic stroke a contraindication to intravenous tissue plasminogen activator (tPA) therapy?

Prior Ischemic Stroke is NOT an Absolute Contraindication to IV tPA

A history of prior ischemic stroke alone does not contraindicate IV tPA administration for acute ischemic stroke. However, the specific combination of prior stroke PLUS diabetes mellitus was historically excluded from the 3-4.5 hour treatment window based on ECASS III trial design, though this restriction has been challenged by real-world evidence.

Key Clinical Distinctions

Prior Stroke Alone (Within 3 Months)

• Original FDA approval (1996) listed "prior stroke within 3 months" as a contraindication
• Current practice has evolved significantly since then 1
• Multiple groups have reported treating patients with prior stroke "off-label" with outcomes better than untreated controls and no increased rates of symptomatic ICH 2

Prior Stroke PLUS Diabetes Mellitus (3-4.5 Hour Window)

This specific combination was excluded from ECASS III, creating a unique contraindication for the extended window:

• Within 0-3 hours: Prior stroke + diabetes is NOT a contraindication
• Within 3-4.5 hours: This combination was historically excluded from ECASS III 2

However, recent registry data challenges this restriction:

• Analysis of 2,129 patients with both prior stroke and diabetes treated with tPA in the 3-4.5 hour window showed:
  • No significant increase in symptomatic ICH (4.3% vs 3.8%, adjusted OR 0.79, p=0.28)
  • No significant increase in mortality (6.2% vs 5.5%, adjusted OR 0.77, p=0.19)
  • Lower functional independence at discharge, but this reflects baseline risk factors rather than tPA harm 3

Practical Algorithm for Decision-Making

When evaluating a patient with prior stroke for tPA:

1. Confirm timing of prior stroke

   • If >3 months ago: Proceed with standard tPA evaluation
   • If <3 months ago: Continue to step 2

2. Check pretreatment CT for old infarct

   • CT evidence of old infarct (even if timing unknown) does NOT increase symptomatic ICH risk (4% vs 2%, p=0.221) 4
   • Do not withhold tPA based solely on CT findings of chronic infarction

3. Assess for diabetes mellitus

   • If NO diabetes: Proceed with tPA in standard 0-4.5 hour window
   • If YES diabetes AND presenting in 3-4.5 hour window: Consider tPA given favorable safety data 3, though this remains technically off-label

4. Exclude prior intracerebral hemorrhage

   • Prior ICH remains a more serious concern, though recent meta-analysis suggests tPA may not significantly increase symptomatic ICH risk (OR 1.57,95% CI 0.78-3.15, p=0.21) 5
   • This requires careful individualized assessment

Important Caveats

• The 2013 AHA/ASA guidelines note that over 15 years of experience with "off-label" fibrinolysis in patients with prior stroke showed better outcomes than untreated controls 2
• The 2015 revision of tPA contraindications removed several previous restrictions, reflecting accumulated real-world safety data 1
• CT evidence of old infarct should not be confused with "recent stroke within 3 months" - the former is NOT a contraindication 4

The bottom line: Unless the prior stroke occurred within the past 3 months AND is clinically documented (not just an incidental CT finding), proceed with standard tPA evaluation. Even the historically excluded combination of prior stroke + diabetes in the 3-4.5 hour window appears safe based on registry data.